PFIZER LTD. - 500680 - Closure of Trading Window
We would like to inform you that, for the purpose of declaration of financial results for the quarter ended June 30, 2020, the trading window of the Company shall remain closed from June 30, 2020 (close of business) till 48 hours after the results are made public. We request you to kindly take the above on record. PFIZER LTD. - 500680 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding loss of share certificates and issue of duplicate share certificates
Buy Pfizer; target of Rs 4705: ICICI Securities
ICICI Securities is bullish on Pfizer recommended buy rating on the stock with a target price of Rs 4705 in its research report dated June 15, 2020. Pfizer Q4 net profit declines 6% to Rs 103 crore
The company had posted a net profit of Rs 109.47 crore in the corresponding period of the previous fiscal. PFIZER LTD. - 500680 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed press release for the audited financial results for the quarter and year ended March 31, 2020. PFIZER LTD. - 500680 - Announcement under Regulation 30 (LODR)-Dividend Updates
The Board of Directors have at its Meeting held today, i.e., June 15, 2020, recommended a final dividend of ?10 per equity share of ?10 each (100%) for the financial year ended March 31, 2020. The said final dividend, if declared at the ensuing General Meeting of the Company shall be paid on or before September 30, 2020. We request you to kindly take the same on record. PFIZER LTD. - 500680 - Board recommends Final Dividend
Pfizer Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 15, 2020, inter alia, have recommended a final dividend of Rs. 10 per equity share of Rs. 10 each (100%) for the financial year ended March 31, 2020. The said final dividend, if declared at the ensuing General Meeting of the Company shall be paid on or before September 30, 2020. PFIZER LTD. - 500680 - Audited Financial Results And Audit Report For The Financial Year Ended March 31, 2020.
Audited financial results and Audit Report for the financial year ended March 31, 2020. PFIZER LTD. - 500680 - Board to consider FY20 results & Final Dividend on June 15, 2020
Pfizer Ltd has informed BSE that a Meeting of the Board of Directors of the Company is scheduled to be held on June 15, 2020, inter alia, to consider and take on record the Audited Financial Results of the Company for the Financial Year ended March 31, 2020 and to consider recommendation of final dividend, if any, for the Financial Year ended March 31, 2020.Further, pursuant to the "Pfizer Limited - Code of Internal Procedures and Conduct to Regulate, Monitor and Report Trading by Insiders", the Trading Window of the Company was closed from April 01, 2020 till 48 hours after the results are made public on June 15, 2020.